MedElevator Войти в исследования
← Поиск публикаций

DOI 10.4137/cmed.s14902

Медицинская библиотека · Clinical medicine insights. Endocrinology and diabetes · 2014

Newer dopaminergic agents cause minimal endocrine effects in idiopathic Parkinson's disease.

Daniel Jacob S, Govindan Jyothish P, Kamath Chandan, D'Souza Charles, Adlan Mohamed A, Premawardhana Lakdasa D

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

We studied the prevalence of endocrine dysfunction in subjects with idiopathic Parkinson's disease (IPD) on newer dopaminergic agents (DA). DA are also used in endocrine hypersecretory states in small doses and we hypothesized that endocrine dysfunction was likely in IPD where DA were used in comparatively much higher dosage.

PATIENTS AND

METHODS

Twenty-five subjects with IPD, established on DA, were recruited to this cross-sectional study. We measured insulin-like growth factor-1, prolactin, luteinizing hormone, follicle stimulating hormone, thyroid function, oestradiol or testosterone and cortisol levels following a short synacthen test.

RESULTS

We studied 18 males and 7 females, whose median age was 72 years, and whose median time from diagnosis, and duration of treatment was 27 months (interquartile range 17-45 and 13-39 months, respectively). (1) Endocrine tests were normal in 19 of 25 subjects at recruitment. Minor abnormalities reverted to normal on repeat testing in three of six with initial abnormalities; two had persistent abnormalities and the third subject could not be further investigated. Therefore, 22 of 24 (92%) with IPD on DA therapy had normal endocrine profiles. (2) The cortisol response to ACTH was normal in 24 of 25 subjects (96%). (3) Eleven subjects (44%) had isolated PRL suppression. There were no differences between the suppressed PRL and "normal" PRL groups. However, a higher number of them were on non-ergoline-derived DA (83% vs 31%; P < 0.05).

CONCLUSIONS

We have demonstrated that newer non-ergoline DA therapy caused only minimal endocrine perturbations in subjects with IPD. Their clinical significance can only be speculative currently. The cortisol response to ACTH was normal in almost all but a significant minority had suppressed prolactin levels.

Для цитирования: Daniel Jacob S, Govindan Jyothish P, Kamath Chandan, D'Souza Charles, Adlan Mohamed A, Premawardhana Lakdasa D. Newer dopaminergic agents cause minimal endocrine effects in idiopathic Parkinson's disease.. Clinical medicine insights. Endocrinology and diabetes. 2014. DOI: 10.4137/cmed.s14902.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.